Explore new findings on ovarian cancer and how blocking focal adhesion kinase can enhance immune response in treatment.

This figure shows the results of treating an aggressive, chemotherapy-resistant ovarian mouse tumor model with an FAK inhibitor and/or a chemotherapy called Pegylated liposomal doxorubicin or PLD.

Want glowing skin? An iron-clad immune system? Better cardiovascular health? Experts will steer your toward vitamin C—more specifically, liposomal vitamin C. “Oral vitamin C (from supplements or food) ...

This article originally appeared on The Conversation. An increasing number of people are dying of colorectal cancer at a young age, including those as young as 20. Actor James Van Der Beek, who was ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

To evaluate the safety and pharmacokinetics of lyso-thermosensitive liposomal doxorubicin (LTLD, ThermoDox®) combined with mitomycin C (MMC) hyperthermic intravesical chemotherapy (HIVEC) as a ...

Paclitaxel (PTX) and cisplatin (CDDP) are conventional chemotherapeutic agents widely used in clinics due to their remarkable antitumor efficacy against various solid tumors. These drugs present ...

Colorectal cancer is now the leading cause of cancer deaths among people younger than 50 in the United States, according to a study published Thursday in the Journal of the American Medical ...

Jenna Scott remembers the joy of being pregnant with her first and only child. She also remembers the immense abdominal pain. During her pregnancy, she let her doctors know about the persistent ...

Most types of cancer have become less deadly over time in adults younger than age 50 in the U.S. but colon and rectum cancers continue to cost lives at alarming rates, according to a new report from ...

The U.S. has reached a watershed moment in the fight against cancer: Seven in 10 people now survive five years or more after diagnosis, according to the latest annual report from the American Cancer ...